Related Targets |
Mechanism Beta-N-acetylhexosaminidase inhibitors [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Mechanism Beta-N-acetylhexosaminidase inhibitors [+2] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Mechanism Beta-N-acetylhexosaminidase inhibitors [+1] |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date24 Feb 2023 |
Sponsor / Collaborator |
Start Date16 Sep 2021 |
Sponsor / Collaborator |
Start Date06 Aug 2020 |
Sponsor / Collaborator |